[Immunointervention in psoriasis. Pathogenic consequences].
Nicolas
J F
JF
INSERM U 346, Clinique Dermatologique, Lyon.
Morel
P
P
Revillard
J P
JP
Thivolet
J
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes; D006801:Humans; D011565:Psoriasis / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy
D000911:Antibodies, Monoclonal
Immuno-intervention dans le psoriasis. Conséquences pathogéniques.